Pharmalot... Pharmalittle... Good Morning

Hello, folks, and how are you today? Summer may be in full swing, but we are as busy as ever here on the Pharmalot corporate campus, where clouds are hovering and wildlife is roaming. Our mission today, which involves reading documents and chatting up interesting people, requires several cups of stimulation. We trust you relate. So grab something stimulating yourself and dig in to the tidbits below. Hope you conquer the world and feel free to write us at ed@pharmalot.com We accept classified information... FTC Asks Actavis For More Info On Warner-Chilcott Deal (Associated Press) Vivus Shareholder To Vote For Dissident Director Slate (Bloomberg News) Former Millenium CEO Dunsire To Head EnVivo Pharma (The Boston Globe) UK's NICE Rejects Celgene Bone Marrow Drug (Reuters) J&J And Pharmacyclics Submit 'Breakthrough' Blood Cancer Drug To FDA (Pharma Times) India To Review Suspension Of Actos And Two Other Drugs (The Business Standard) FDA Looks To Update And Improve Drug Labeling (Regulatory Focus) ...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs